A prospective,multicenter,non-interventional study to evaluate the outcomes in patients with Psoriatic arthritis treated with ustekinumab

Trial Profile

A prospective,multicenter,non-interventional study to evaluate the outcomes in patients with Psoriatic arthritis treated with ustekinumab

Recruiting
Phase of Trial: Phase III

Latest Information Update: 04 Jul 2017

At a glance

  • Drugs Ustekinumab (Primary)
  • Indications Psoriatic arthritis
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SUSTAIN
  • Most Recent Events

    • 04 Jul 2017 New trial record
    • 17 Jun 2017 First interim results (n=189) assessing efficacy and safety presented at the 18th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top